Beta-receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair?

[1]  A. Wessel,et al.  Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. , 2001, International journal of cardiology.

[2]  D. Gozal,et al.  Pulmonary risk factors compromising postoperative recovery after surgical repair for congenital heart disease. , 1999, Chest.

[3]  K. Werdan,et al.  A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease. , 1997, European journal of pharmacology.

[4]  W. Abraham,et al.  Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. , 1996, Circulation.

[5]  Jiunn-Ren Wu,et al.  Reduction in lymphoctye β-adreneraic receptor density in infants and children with heart failure secondary to congenital heart disease , 1996 .

[6]  N. Dzimiri,et al.  Regulation of Sympathetic Activity in Children with Various Congenital Heart Diseases , 1995, Pediatric Research.

[7]  M. Chester,et al.  Beta adrenoceptor density in the donor heart: a guide to prognosis? , 1995, British heart journal.

[8]  H. Kramer,et al.  Distribution of Myocardial β‐Adrenoceptor Subtypes and Coupling to the Adenylate Cyclase in Children With Congenital Heart Disease and Implications for Treatment , 1993 .

[9]  M. Michel,et al.  Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. , 1989, Journal of the American College of Cardiology.